title: [TIL (tumor-infiltrating lymphocytes): a new therapeutic approach for metastasizing kidney cancer].
authors.affiliation: Clinique urologique, Hôpital Cochin, Paris.
authors.forename: N
authors.initials: N
authors.lastname: Thiounn
authors.forename: C
authors.initials: C
authors.lastname: Peyret
authors.forename: T
authors.initials: T
authors.lastname: Flam
authors.forename: M
authors.initials: M
authors.lastname: Zerbib
authors.forename: B
authors.initials: B
authors.lastname: Debré
mesh_terms: D002478:Cells, Cultured; D016219:Immunotherapy, Adoptive / Q000379:methods*; D007376:Interleukin-2 / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D016246:Lymphocytes, Tumor-Infiltrating; D008285:Major Histocompatibility Complex / Q000276:immunology; D009362:Neoplasm Metastasis; D014407:Tumor Cells, Cultured
chemical_list: D007376:Interleukin-2
vernacular_title: Les til: une nouvelle approche thérapeutique pour les cancers du rein métastasés.